Cargando…

Synaptic protein dysregulation in myotonic dystrophy type 1: Disease neuropathogenesis beyond missplicing

The toxicity of expanded transcripts in myotonic dystrophy type 1 (DM1) is mainly mediated by the disruption of alternative splicing. However, the detailed disease mechanisms in the central nervous system (CNS) have not been fully elucidated. In our recent study, we demonstrated that the accumulatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hernández-Hernández, Oscar, Sicot, Géraldine, Dinca, Diana M., Huguet, Aline, Nicole, Annie, Buée, Luc, Munnich, Arnold, Sergeant, Nicolas, Gourdon, Geneviève, Gomes-Pereira, Mário
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Addendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927487/ https://www.ncbi.nlm.nih.gov/pubmed/25003003 http://dx.doi.org/10.4161/rdis.25553

Ejemplares similares

Downregulation of the Glial GLT1 Glutamate Transporter and Purkinje Cell Dysfunction in a Mouse Model of Myotonic Dystrophy
por: Sicot, Géraldine, et al.
Publicado: (2017)

GSK3β is a new therapeutic target for myotonic dystrophy type 1
por: Wei, Christina, et al.
Publicado: (2013)

TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2
por: Bosè, Francesca, et al.
Publicado: (2019)

Myotonic dystrophy RNA toxicity alters morphology, adhesion and migration of mouse and human astrocytes
por: Dincã, Diana M., et al.
Publicado: (2022)

Staufen1s role as a splicing factor and a disease modifier in Myotonic Dystrophy Type I
por: Bondy-Chorney, Emma, et al.
Publicado: (2016)

Author Correction: Myotonic dystrophy RNA toxicity alters morphology, adhesion and migration of mouse and human astrocytes
por: Dincã, Diana M., et al.
Publicado: (2022)

Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS
por: Gourdon, Genevieve, et al.
Publicado: (2017)

Of Mice and Men: Advances in the Understanding of Neuromuscular Aspects of Myotonic Dystrophy
por: Braz, Sandra O., et al.
Publicado: (2018)

Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy
por: Caillet-Boudin, Marie-Laure, et al.
Publicado: (2014)

Facioscapulohumeral muscular dystrophy: Are telomeres the end of the story?
por: Stadler, Guido, et al.
Publicado: (2013)

Transcriptionally Repressive Chromatin Remodelling and CpG Methylation in the Presence of Expanded CTG-Repeats at the DM1 Locus
por: Brouwer, Judith Rixt, et al.
Publicado: (2013)

The immune system in Duchenne muscular dystrophy: Friend or foe
por: Villalta, S Armando, et al.
Publicado: (2015)

Simvastatin offers new prospects for the treatment of Duchenne muscular dystrophy
por: Whitehead, Nicholas P., et al.
Publicado: (2016)

Straightjacket/α2δ3 deregulation is associated with cardiac conduction defects in myotonic dystrophy type 1
por: Auxerre-Plantié, Emilie, et al.
Publicado: (2019)

Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1
por: Voellenkle, Christine, et al.
Publicado: (2019)

Drosophila as a starting point for developing therapeutics for the rare disease Duchenne Muscular Dystrophy
por: Pantoja, Mario, et al.
Publicado: (2013)

Muscle-specific microRNAs as biomarkers of Duchenne Muscular Dystrophy progression and response to therapies
por: Giordani, L, et al.
Publicado: (2014)

RNA Toxicity and Missplicing in the Common Eye Disease Fuchs Endothelial Corneal Dystrophy
por: Du, Jintang, et al.
Publicado: (2015)

Therapeutic Targeting of the GSK3β-CUGBP1 Pathway in Myotonic Dystrophy
por: Lutz, Maggie, et al.
Publicado: (2023)

A Drosophila screen identifies neurofibromatosis-1 genetic modifiers involved in systemic and synaptic growth
por: Walker, James A, et al.
Publicado: (2014)

Functional and histopathological identification of the respiratory failure in a DMSXL transgenic mouse model of myotonic dystrophy
por: Panaite, Petrica-Adrian, et al.
Publicado: (2013)

RBFOX1 Cooperates with MBNL1 to Control Splicing in Muscle, Including Events Altered in Myotonic Dystrophy Type 1
por: Klinck, Roscoe, et al.
Publicado: (2014)

Addendum: Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways
por: Howard, David M., et al.
Publicado: (2018)

CTG Trinucleotide Repeat “Big Jumps”: Large Expansions, Small Mice
por: Gomes-Pereira, Mário, et al.
Publicado: (2007)

Myotonic dystrophy
por: Patterson, VH
Publicado: (1990)

Electrophysiological basis of cardiac arrhythmia in a mouse model of myotonic dystrophy type 1
por: Ginjupalli, Vamsi Krishna Murthy, et al.
Publicado: (2023)

Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 Mice
por: Jauvin, Dominic, et al.
Publicado: (2017)

The initiation of post-synaptic protrusions
por: Hotulainen, Pirta, et al.
Publicado: (2016)

Addendum: Morén, C.; Hernández, S.; Guitart-Mampel, M.; Garrabou, G. Mitochondrial Toxicity in Human Pregnancy: An Update on Clinical and Experimental Approaches in the Last 10 Years. Int. J. Environ. Res. Public Health 2014, 11, 9897–9918
por: Morén, Constanza, et al.
Publicado: (2016)

Dynamics and variability of transcriptomic dysregulation in congenital myotonic dystrophy during pediatric development
por: Hale, Melissa A, et al.
Publicado: (2022)

Methamphetamine Dysregulates Macrophage Functions and Autophagy to Mediate HIV Neuropathogenesis
por: Barbaro, John M., et al.
Publicado: (2022)

The impact of the genetic background in the Noonan syndrome phenotype induced by K-Ras(V14I)
por: Hernández-Porras, Isabel, et al.
Publicado: (2015)

Cancer and Myotonic Dystrophy
por: D’Ambrosio, Eleonora S., et al.
Publicado: (2023)

Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1
por: Ait Benichou, Siham, et al.
Publicado: (2022)

Rab11 as a modulator of synaptic transmission
por: Giorgini, Flaviano, et al.
Publicado: (2013)

Prion protein as a mediator of synaptic transmission
por: Steinert, Joern R
Publicado: (2015)

Addendum: Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma
por: Teixidor, Eduard, et al.
Publicado: (2023)

Transcriptional signatures of synaptic vesicle genes define myotonic dystrophy type I neurodegeneration
por: Jimenez‐Marin, Antonio, et al.
Publicado: (2021)

PRPF8 Defects Cause Missplicing in Myeloid Malignancies
por: Kurtovic-Kozaric, Amina, et al.
Publicado: (2014)

Desflurane anaesthesia in myotonic dystrophy
por: Gandhi, Ranju, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ujkbh6ub6as9b7rqmhg93g6s8g